Chronic traumatic encephalopathy is a progressive tauopathy that occurs as a consequence of repetitive mild traumatic brain 35 injury. We analysed post-mortem brains obtained from a cohort of 85 subjects with histories of repetitive mild traumatic brain injury and found evidence of chronic traumatic encephalopathy in 68 subjects: all males, ranging in age from 17 to 98 years (mean 59.5 years), including 64 athletes, 21 military veterans (86% of whom were also athletes) and one individual who engaged in self-injurious head banging behaviour. Eighteen age-and gender-matched individuals without a history of repetitive mild traumatic brain injury served as control subjects. In chronic traumatic encephalopathy, the spectrum of hyperphosphory-40 lated tau pathology ranged in severity from focal perivascular epicentres of neurofibrillary tangles in the frontal neocortex to severe tauopathy affecting widespread brain regions, including the medial temporal lobe, thereby allowing a progressive staging of pathology from stages I-IV. Multifocal axonal varicosities and axonal loss were found in deep cortex and subcortical white matter at all stages of chronic traumatic encephalopathy. TAR DNA-binding protein 43 immunoreactive inclusions and neurites were also found in 85% of cases, ranging from focal pathology in stages I-III to widespread inclusions and neurites in stage IV. Symptoms in stage I chronic traumatic encephalopathy included headache and loss of attention and concentration. Additional symptoms in stage II included depression, explosivity and short-term memory loss. In stage III, executive dysfunction and cognitive 5 impairment were found, and in stage IV, dementia, word-finding difficulty and aggression were characteristic. Data on athletic exposure were available for 34 American football players; the stage of chronic traumatic encephalopathy correlated with increased duration of football play, survival after football and age at death. Chronic traumatic encephalopathy was the sole diagnosis in 43 cases (63%); eight were also diagnosed with motor neuron disease (12%), seven with Alzheimer's disease (11%), 11 with Lewy body disease (16%) and four with frontotemporal lobar degeneration (6%). There is an ordered and predictable progression 10 of hyperphosphorylated tau abnormalities through the nervous system in chronic traumatic encephalopathy that occurs in conjunction with widespread axonal disruption and loss. The frequent association of chronic traumatic encephalopathy with other neurodegenerative disorders suggests that repetitive brain trauma and hyperphosphorylated tau protein deposition promote the accumulation of other abnormally aggregated proteins including TAR DNA-binding protein 43, amyloid beta protein and alpha-synuclein. 
matter at all stages of chronic traumatic encephalopathy. TAR DNA-binding protein 43 immunoreactive inclusions and neurites were also found in 85% of cases, ranging from focal pathology in stages I-III to widespread inclusions and neurites in stage IV. Symptoms in stage I chronic traumatic encephalopathy included headache and loss of attention and concentration. Additional symptoms in stage II included depression, explosivity and short-term memory loss. In stage III, executive dysfunction and cognitive impairment were found, and in stage IV, dementia, word-finding difficulty and aggression were characteristic. Data on athletic exposure were available for 34 American football players; the stage of chronic traumatic encephalopathy correlated with increased duration of football play, survival after football and age at death. Chronic traumatic encephalopathy was the sole diagnosis in 43 cases (63%); eight were also diagnosed with motor neuron disease (12%), seven with Alzheimer's disease (11%), 11 with Lewy body disease (16%) and four with frontotemporal lobar degeneration (6%). There is an ordered and predictable progression
Introduction
Repetitive mild traumatic brain injury can trigger the development of chronic traumatic encephalopathy (CTE), a progressive neuro-20 degeneration characterized by the widespread deposition of hyperphosphorylated tau (p-tau) as neurofibrillary tangles (Corsellis and Brierley, 1959; Corsellis et al., 1973 , Hof et al., 1991 Geddes et al., 1999; Omalu et al., 2005 Omalu et al., , 2006 Omalu et al., , 2010 McKee et al., 2009 McKee et al., , 2010 Gavett et al., 2010 Gavett et al., , 2011 Daneshvar 25 et al., 2011a, b; Costanza et al., 2011; Stern et al., 2011; Goldstein et al., 2012; Saing et al., 2012) . CTE was originally reported in 1928 by Harrison Martland, a New Jersey pathologist, who described the clinical aspects of a progressive neurological deterioration ('punch drunk') that occurred after repetitive brain 30 trauma in boxers (Martland, 1928) . Although originally termed 'dementia pugilistica' (Millspaugh, 1937) , the recognition that activities other than boxing were associated with its development lead to the preferred use of terms such as progressive traumatic encephalopathy and later, CTE (Critchley, 1949; 1957) .
35
CTE is clinically associated with symptoms of irritability, impulsivity, aggression, depression, short-term memory loss and heightened suicidality that usually begin 8-10 years after experiencing repetitive mild traumatic brain injury (McKee et al., 2009) . With advancing disease, more severe neurological changes develop that 40 include dementia, gait and speech abnormalities and parkinsonism. In late stages, CTE may be clinically mistaken for Alzheimer's disease or frontotemporal dementia (Gavett et al., , 2011 . A subset of cases with CTE is associated with motor neuron disease (MND) . 45 The neuropathological changes of CTE are distinctive and easily distinguished from other tauopathies, including Alzheimer's disease. The neuropathological features of CTE include generalized atrophy of the cerebral cortex, medial temporal lobe, diencephalon and mammillary bodies with enlarged ventricles; cavum 50 septum pellucidum, often with fenestrations; extensive p-tau-immunoreactive neurofibrillary tangles and astrocytic tangles in the frontal and temporal cortices, particularly around small cerebral vessels and at the depths of cerebral sulci; extensive p-tau-immunoreactive neurofibrillary tangles in limbic regions, di-55 encephalon and brainstem nuclei; extensive degeneration of axons and white matter fibre bundles; TAR DNA-binding protein 43 (TDP-43) immunoreactive intraneuronal and intraglial inclusions and neurites in most cases and a relative absence of amyloid-b peptide deposits (Corsellis and Brierley, 1959; Corsellis et al., 60 1973; Hof et al., 1991; Geddes et al., 1999; Omalu et al., 2005 Omalu et al., , 2006 Omalu et al., , 2010 McKee et al., 2009 McKee et al., , 2010 Gavett et al., 2010 Gavett et al., , 2011 Daneshvar et al., 2011a, b; Costanza et al., 2011; Stern et al., 2011; Goldstein et al., 2012; Saing et al., 2012) .
In 2008, the Center for the Study of Traumatic Encephalopathy
Materials and methods

Subjects
A total of 85 brains from former athletes, military veterans or civilians with a history of repetitive mild traumatic brain injury were compre-5 hensively evaluated. Eighteen additional brains from cognitively intact individuals without history of mild traumatic brain injury were obtained from the Boston University Alzheimer's Disease Center Brain Bank that included some subjects from the Framingham Heart Study. Next of kin provided written consent for participation and brain donation.
Institutional review board approval for brain donation was obtained through the Boston University Alzheimer's Disease Center, CSTE and the Bedford VA Hospital. Institutional review board approval for post-mortem clinical record review, interviews with family members and neuropathological evaluation was obtained through Boston
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University School of Medicine.
Clinical assessment
Concussion and mild traumatic brain injury history, history of cognitive and behavioural changes and clinical status leading up to death were determined through post-mortem interviews with next of kin per-
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formed by a neuropsychologist (R.A.S.) who was blind to the results of the neuropathological examination at the time of interview. Informants were interviewed before receiving the results of the neuropathological examination. The interview was semi-structured and conducted by telephone. Areas queried included demographics, athletic 25 history, military service, concussion and brain trauma history, medical history (including neurological, psychiatric and substance use), family history, social/occupational history, and reported/observed changes in mood, behaviour, motor functions, cognition and activities of daily living. To semi-quantify cognitive, mood and functional 30 changes, modifications of standard measures/interviews were administered to the informant to assess their perception of the subject in the months or years before death (Pfeffer et al., 1982; McNair et al., 1984; Brown and Schinka, 2005; Galvin et al., 2005) . Medical record review was also performed (R.A.S. and A.C.M.).
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In analysis of the clinical symptoms associated with CTE, case selection was restricted to those cases with post-mortem semi-structured family interviews and pathological diagnosis of CTE or CTE plus MND (CTE-MND), without other co-morbidities.
Duration of exposure to American
football and position played
To examine the relationship between exposure and stage of CTE, analyses were performed on the subset of athletes who played American football. Only football played at the high school level or higher was considered for these analyses. Of the 85 brain donors, 45 58 played American football as their primary sport. Of those, 16 subjects were excluded owing to comorbid disease (Alzheimer's disease, Parkinson's disease, Lewy body disease, FTLD and multiple system atrophy), and seven were excluded owing to incomplete athletic information. Football players were also grouped by primary position 50 played: offensive and defensive linemen, quarterbacks, wide receivers, all other offensive backs, defensive linebackers and defensive backs.
Neuropathological examination
The neuropathological processing followed the procedures previously 55 established for the Boston University Alzheimer's Disease Center Brain Bank (Vonsattel et al., 1995) . Paraffin-embedded sections were stained with Luxol fast blue, haematoxylin and eosin, Bielschowsky's silver, AT8, alpha-synuclein, amyloid-ß, TDP-43, phosphorylated TDP-43 (pTDP-43), SMI-31 and SMI-34 using methods described pre-60 viously (McKee et al., 2009 ). In addition, multiple large coronal slabs of the cerebral hemispheres were cut at 50 mm on a sledge microtome and stained as free-floating sections using AT8, amyloid-ß, TDP-43, pTDP-43, CP13 and PHF-1 (McKee et al., 2009, 2010 
Neuropathological diagnoses Definition of chronic traumatic encephalopathy
Based on our previous studies and review of the literature on CTE 70 (Corsellis et al., 1973; Hof et al., 1991; Geddes et al., 1999; Omalu et al., 2005 Omalu et al., , 2006 Omalu et al., , 2010 McKee et al., 2009 McKee et al., , 2010 Goldstein et al., 2012; Saing et al., 2012) , the diagnosis of CTE was defined by the presence of the following criteria (Table 1 and Figs. 1 and 2): (i) perivascular foci of p-tau immunoreactive astrocytic tangles and 75 neurofibrillary tangles; (ii) irregular cortical distribution of p-tau immunoreactive neurofibrillary tangles and astrocytic tangles with a predilection for the depth of cerebral sulci; (iii) clusters of subpial and periventricular astrocytic tangles in the cerebral cortex, diencephalon, basal ganglia and brainstem; and (iv) neurofibrillary tangles in the 80 cerebral cortex located preferentially in the superficial layers.
Definition of chronic traumatic encephalopathy-motor neuron disease
The diagnosis of CTE-MND required a clinical diagnosis of definite amyotrophic lateral sclerosis using the revised El Escorial criteria for 85 the diagnosis of amyotrophic lateral sclerosis (Brook et al., 1994 (Brook et al., , 2000 , and the pathological diagnosis of CTE, as defined above, in addition to the following criteria 
Criteria for Alzheimer's disease
The criteria for Alzheimer's disease were based on the presence of 95 amyloid-ß neuritic plaques and p-tau neurofibrillary tangles according to the NIA-Reagan criteria for intermediate and high likelihood Alzheimer's disease and the recent NIA Alzheimer Association's guidelines (Newell et al., 1999; Montine et al., 2012) . The NIA-Reagan criteria take into account both the Braak and Braak staging of neuro-100 fibrillary tangles (Braak and Braak, 1991 and the overall density of neuritic plaques based on CERAD criteria (Mirra et al., 1991) . The nature, pattern and distribution of p-tau neurofibrillary degeneration in CTE are distinctive from Alzheimer's disease (Table 1 and Fig. 1 ; McKee et al., 2011) .
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Criteria for Parkinson's disease and Lewy body disease
The diagnosis of Parkinson's disease or Lewy body disease was based on the presence and distribution of alpha-synuclein-positive Lewy bodies and was considered brainstem-predominant (Parkinson's disease), limbic or transitional Lewy body disease, and neocortical or diffuse Lewy body disease as defined by McKeith criteria (McKeith et al., 1996) and Braak staging (Del Tredici et al., 2002; Braak and 5 Del Tredici, 2008) .
Criteria for frontotemporal lobar degeneration
Neuropathological diagnosis of FTLD was based on predominant involvement of the frontal and temporal lobes and characteristic immunohistochemistry for p-tau, TDP-43 and p-TDP-43 using established criteria for FTLD (Cairns et al., 2007; Bigio, 2008; Mackenzie et al., 2010) . The most common FTLD, FTLD with TDP-43-positive inclusions, FTLD-TDP, was defined by TDP-43-positive neuronal cytoplasmic and intranuclear inclusions, dystrophic neurites and glial cytoplasmic inclusions in the superficial layers of cerebral cortex and 15 dentate gyrus. The diagnosis of FTLD-tau, which includes progressive supranuclear palsy, corticobasal degeneration and Pick's disease, was defined by the specific patterns of p-tau glial and neuronal pathology and neuroanatomical areas of involvement according to consensus criteria (Litvan et al., 1996; Cairns et al., 2007; Dickson, 2009 ).
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If criteria for more than one neurodegenerative disease were present, the case was considered to be mixed disease. Diagnosis of multiple system atrophy was based on published criteria (Dickson et al., 2009 ).
Semi-quantitative assessment of neuropathological
features
The density of neurofibrillary tangles, astrocytic tangles, diffuse and neuritic amyloid-b plaques and vascular amyloid was rated semiquantitatively using AT8 or amyloid-ß immunostained paraffinembedded 10 mm sections according to methods previously reported 
Apolipoprotein E genotyping
Apolipoprotein E (ApoE) genotyping was conducted using restriction isotyping for determining ApoE isoforms based on brain tissue samples.
Statistical analysis
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Stage of CTE was treated as an inexact ordinal variable; Spearman's rank order correlation was used to determine the statistical dependence between CTE stage and all linear variables of interest (e.g. age, years of education, total number of reported concussions, total number of years of American football played and number of years 40 between retirement and death). For non-linear independent variables, the Wilcoxon-Mann-Whitney two-sample rank-sum test was used for 
independent variables with only two groups (e.g. lifetime history of steroid use, presence of at least one ApoE e4 allele), whereas the Kruskall-Wallis test was used for variables with more than two groupings (e.g. position played).
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Additionally, to determine whether the proportion of individuals with at least one ApoE e4 allele was higher in individuals diagnosed with CTE, a Chi-square goodness of fit test was performed comparing all CTE cases (n = 65) with the expected proportion in the US population (Corder et al., 1993) .
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Results
The 85 brain donors with a history of mild traumatic brain injury included 80 athletes (22 of whom were also military veterans), three military veterans with no history of contact sports, one civilian who had experienced multiple falls and one individual who engaged in self-injurious repetitive head-banging behaviour (84 males, one female, age range 14-98 years, mean 54.1 AE 23.3 years) ( Table 2 ). We also analysed the brains of 18 cognitively intact subjects without known history of repetitive mild traumatic brain injury (17 males: one female, age range 18-88 years, mean 20 62.0 AE 17.4 years), seven of whom were military veterans and three of whom were athletes (skiing, sailing, golf and trap shooting) with no known history of mild traumatic brain injury.
Pathological findings
Seven of the 18 control brains were completely negative for p-tau 25 neurofibrillary tangles (mean age 48.1 AE 19.8 years), 11 control brains showed Alzheimer's-type neurofibrillary pathology limited to the hippocampus and entorhinal cortex consistent with Braak neurofibrillary stages I and II (mean age 70.8 AE 7.8 years). Three control subjects showed small amounts of amyloid-ß deposition as 30 diffuse, neuritic plaques or vascular amyloid (mean 69.7 AE 8.1 years). No control case showed evidence of perivascular clusters of neurofibrillary tangles or astrocytic tangles, neurofibrillary tangles localized to the depths of the cerebral sulci or neurofibrillary tangles primarily localized to the superficial cortical laminae
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( Table 2 , Cases 1-18).
Brains from 17 of the 85 individuals with a history of repetitive mild traumatic brain injury (16 males: one female; mean age 32.6 AE 22.4 years, 20% of the mild traumatic brain injury sample) did not show any changes of CTE ( without a history of contact sports also developed CTE including three veterans and one individual who displayed self-injurious head banging behaviour. CTE or CTE-MND was diagnosed in 51 cases (51 males, 0 females, mean age 55.3 AE 21.8 years; 60% of the mild traumatic brain injury sample, 75% of all CTE cases). brain injury sample, 11.8% of CTE cases) ( (Table 2) .
Amyloid-b and Lewy bodies
Amyloid-ß deposition, either as diffuse plaques, neuritic plaques or vascular amyloid, was found in 30 brains (35.3% of the mild trau-15 matic brain injury sample, 44.1% of CTE cases) and 14 (27.4%) pure CTE cases. Subjects with CTE and pure CTE whose brains showed amyloid-ß deposits were significantly older than those without amyloid-ß (P 5 0.0001; P 5 0.0001). Alpha-synucleinpositive Lewy bodies were found in 15 of the CTE cases
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(22.0%). In two cases with CTE, Lewy bodies were restricted to the olfactory bulb and medulla, and in two cases with CTE plus Alzheimer's disease, Lewy bodies were restricted to the amygdala. Subjects with Lewy bodies were significantly older than those without (P = 0.03).
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Neuropathology of chronic traumatic encephalopathy
In individuals with CTE or CTE-MND, 13 had diffuse plaques (25.5%), 10 had modest numbers of neuritic plaques (19.6%) and seven had small amounts of vascular amyloid (13.7%). These 30 51 brains showed a predictable range of unique p-tau pathology that could be divided into four distinct stages of disease (Figs 1-3 ). CTE disease severity ranged from very mild (stage I/IV, n = 7, age range 17-56 years, mean 28.3 years AE 13.5), mild (stage II/IV, n = 14, age range 21-87 years, mean 44.3 years AE 16.7), moderate
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(stage III/IV, n = 15, age range 38-82 years, mean 56.0 years AE 14.2) to severe (stage IV/IV, n = 15, age range 51-98 years, mean 77.4 years AE 11.7) ( Table 2 and Supplementary  Tables 3 and 4 ). The p-tau neurofibrillary tangles at all stages were immunoreactive for both 3 R and 4 R tau, and astrocytic tan-40 gles were predominantly immunoreactive for 4 R tau (Fig. 2) .
Stage I chronic traumatic encephalopathy
Seven brains showed stage I CTE ( the epicentres was unremarkable except for rare isolated neurofibrillary tangles in superficial laminae. Low densities of neurofibrillary tangles were found in the locus coeruleus in two cases. One case showed sparse neurofibrillary tangles in the hippocam-5 pus, entorhinal cortex and substantia nigra; another case displayed p-tau neurofibrillary tangles and distorted axonal profiles in the medulla (Case 37). Phosphorylated neurofilament immunohistochemistry showed scattered distorted axonal varicosities in frontal cortex, subcortical white matter and deep white matter tracts of 10 the diencephalon, which were also occasionally immunoreactive for p-tau (Fig. 4) . TDP-43 immunopositive neurites were found in four of the seven cases (57%) in the frontal subcortical white matter and fornix.
Clinical symptoms
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Family interview and medical record review were available in six of the seven subjects with stage I CTE. One subject was asymptomatic. Four of the six reported headache and loss of attention and concentration, three reported short-term memory difficulties, aggressive tendencies and depression and two reported executive 20 dysfunction and explosivity. Two subjects were diagnosed with post-traumatic stress disorder (Tables 3 and 4) .
Stage II chronic traumatic encephalopathy
Fourteen brains showed stage II pathology (Table 2 , Cases 43-56).
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Grossly, there was no evidence of cerebral atrophy with a mean brain weight of 1463.3 AE 100.1 g. There was mild enlargement of the frontal horn of the lateral ventricles or third ventricle in 6 of the 11 intact specimens, and a small cavum septum (0.2-0.7 cm) was found in four; the third ventricle was enlarged and sharply 30 concave in three. Three cases showed pallor of the locus coeruleus and substantia nigra. There was severe gliosis and atrophy of one mammillary body in one case (Case 45). P-tau pathology was found in multiple discrete foci of the cortex, most commonly superior, dorsolateral, lateral, inferior and subcallosal frontal, anterior, inferior 35 and lateral temporal, inferior parietal, insular and septal cortices. Neurofibrillary tangles were also found in the superficial layers of cortex ( Figs. 1 and 3 ). Moderate densities of neurofibrillary tangles were also found in the locus coeruleus, nucleus basalis of Meynert and amygdala even in the younger individuals (Fig. 4 and Supple-40 mentary Table 3 ). Low densities of p-tau neurofibrillary tangles and Figure 3 The four stages of CTE. In stage I CTE, p-tau pathology is restricted to discrete foci in the cerebral cortex, most commonly in the superior, dorsolateral or lateral frontal cortices, and typically around small vessels at the depths of sulci (black circles). In stage II CTE, there are multiple epicentres at the depths of the cerebral sulci and localized spread of neurofibrillary pathology from these epicentres to the superficial layers of adjacent cortex. The medial temporal lobe is Figure 3 Continued spared neurofibrillary p-tau pathology in stage II CTE. In stage III, p-tau pathology is widespread; the frontal, insular, temporal and parietal cortices show neurofibrillary degeneration with greatest severity in the frontal and temporal lobe, concentrated at the depths of the sulci. Also in stage III CTE, the amygdala, hippocampus and entorhinal cortex show neurofibrillary pathology. In stage IV CTE, there is severe p-tau pathology affecting most regions of the cerebral cortex and the medial temporal lobe, sparing calcarine cortex in all but the most severe cases. All images, CP-13 immunostained 50-mm tissue sections. Figure 4 Hyperphosphorylated tau pathology in the four stages of CTE. In stage I CTE (first column), p-tau pathology is found in limited discrete perivascular foci (A), typically at the depths of sulci or around small vessels. There is mild p-tau pathology in cerebral cortices neighbouring the epicentres (E). There is no or minimal p-tau pathology in the amygdala (I) or CA1 of hippocampus (M). Occasional p-tau neurites are found in the nucleus basalis of Meynert (Q) and substantia nigra (U); isolated neurofibrillary tangles are present in the locus coeruleus (Y) in stage I. In stage II CTE (second column), there is spread of pathology from focal epicentres (B) to the superficial layers of adjacent cortex (F). The medial temporal lobe shows only mild neurofibrillary pathology, including amygdala (J) and CA1 hippocampus (N). Nucleus basalis of Meynert (R) and locus coeruleus (Z) demonstrate moderate p-tau pathology as neurofibrillary tangles and neurites; the substantia nigra (V) shows only modest pathology. In stage III, p-tau pathology is severe and widespread throughout the frontal, insular, temporal and parietal cortices. The cortical epicentres and depths of the sulci often consist of confluent masses of neurofibrillary tangles and astrocytic tangles (C). The intervening cortices show advanced neurofibrillary degeneration (G). The amygdala (K), hippocampus (O) and entorhinal cortex demonstrate marked neurofibrillary pathology. The nucleus basalis of Meynert shows dense neurofibrillary tangles (S); the locus coeruleus (AA) shows advanced neurofibrillary pathology, and the substantia nigra is moderately affected (W) in stage III CTE. In stage IV CTE, there is widespread p-tau pathology affecting most regions of the cerebral cortex and medial temporal lobe with relative sparing of the calcarine cortex. Astrocytic tangles are prominent, and there is marked neuronal loss in the cortex, amygdala and hippocampus. Phosphorylated-tau neurofibrillary tangles are reduced in size and density. The cortical epicentres show severe neuronal loss and prominent astrocytic tangles (D); similar changes are found throughout the frontal, temporal and parietal cortices (H). The amygdala demonstrates intense gliosis and p-tau neuronal and glial degeneration (L). The hippocampus is sclerotic with marked neuronal loss, gliosis, ghost neurofibrillary tangles and astrocytic tangles (P). The nucleus basalis of Meynert shows marked neurofibrillary pathology and gliosis (T); the substantia nigra (X) and locus coeruleus (BB) show advanced neurofibrillary pathology. All images: CP-13 immunostained 50 -mm tissue sections, some counterstained with cresyl violet, all scale bars = 100 mm. pretangles were present in the hypothalamus, CA1 of hippocampus, entorhinal cortex, thalamus, substantia nigra and dorsal and median raphe nuclei of the midbrain. Distorted axonal varicosities, some p-tau immunoreactive, were found in frontal and temporal cortices 5 as well as white matter tracts (Figs. 1 and 5) . Eleven of the 14 subjects with stage II CTE also showed TDP-43 immunopositivity (79%). TDP-43 immunopositivity consisted of rare neurites or inclusions in the cerebral subcortical white matter, brainstem or medial temporal lobe in eight cases, often in a subpial, periventricular or 10 perivascular distribution (Fig. 6) . Three subjects showed severe TDP-43 abnormalities as neuronal and glial inclusions and neurites in widespread regions of the CNS, including the cerebral hemispheres, basal ganglia, diencephalon, brainstem, anterior horn cells and white matter tracts of the spinal cord (Fig. 6) . These cases also 
Clinical symptoms
Eleven of the 14 individuals with stage II CTE were symptomatic; 20 common presenting symptoms were depression or mood swings, headaches and short-term memory loss. Three subjects presented with symptoms of MND. Symptoms in stage II subjects included depression or mood lability, explosivity, loss of attention and concentration, short-term memory loss and headache. Less common 25 symptoms included executive dysfunction, impulsivity, suicidality and language difficulties (Tables 3 and 4) .
Stage III chronic traumatic encephalopathy
Fifteen brains showed stage III pathology (Table 2 , Cases 57-71).
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Grossly, most brains showed mild cerebral atrophy with dilation of the lateral and third ventricles; mean brain weight was 1394 AE 106.7 g. Septal abnormalities were found in 5 of the 12 intact brain specimens (42%) ranging from cavum septum, septal perforations or complete absence of the septum. Seven brains 35 showed moderate depigmentation of the locus coeruleus (58%); six showed mild depigmentation of the substantia nigra (42%).
Other common gross pathological features were atrophy of the mammillary bodies and thalamus, sharply convex contour of the medial thalamus, thinning of the hypothalamic floor and thinning
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of the corpus callosum. Microscopically, neurofibrillary tangles were widespread throughout superior frontal, dorsolateral frontal, inferior orbital, septal, insular, temporal pole, superior middle and inferior temporal and inferior parietal cortices. There were also extensive neurofibrillary tangles in the hippocampus, entorhinal 45 cortex, amygdala, nucleus basalis of Meynert and locus coeruleus (Supplementary Table 3 ). Neurofibrillary tangles were frequent in olfactory bulbs, hypothalamus, mammillary bodies, substantia nigra and dorsal and median raphe nuclei. Sparse neurofibrillary tangles were found in Rolandic, cingulate cortices, thalamus, nu-50 cleus accumbens, dorsal motor nucleus of the vagus, dentate nucleus of the cerebellum and spinal cord. Severe axonal loss and distorted axonal profiles were found in the subcortical white matter, particularly affecting the frontal and temporal cortices (Fig. 5) . TDP-43 immunoreactive neurites were evident in the cerebral cortex, medial temporal lobe or brainstem of most cases. Widespread, more severe TDP-43 neuronal and glial inclusions and neurites were found in three cases with stage III CTE diagnosed with CTE-MND.
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Clinical symptoms
Family interview and medical record review were available for 12 subjects with stage III CTE; one individual was asymptomatic (Case 68). The most common presenting symptoms were memory loss, executive dysfunction, explosivity and difficulty with attention and 10 concentration. Other symptoms frequently found in stage III subjects were depression or mood swings, visuospatial difficulties and aggression. Less common symptoms included impulsivity, apathy, headaches and suicidality. Seventy-five per cent of subjects were considered cognitively impaired. Two subjects developed symp-
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toms of MND after the onset of cognitive or behavioural abnormalities, another developed cognitive changes after the onset of MND (Tables 3 and 4) . 
Stage IV chronic traumatic encephalopathy
Fifteen individuals were considered to have stage IV CTE ( tricle, cavum septum pellucidum ranging in size from 0.5 to 1.0 cm, and septal perforations or septal absence. Pallor of the locus coeruleus and substantia nigra were found in all instances where it could be assessed. Microscopically, there was striking neuronal loss in the cortex, hippocampal sclerosis affecting CA1
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and subiculum and astrocytic p-tau pathology. Severe p-tau abnormalities were found widely distributed throughout the cerebrum, diencephalon, basal ganglia, brainstem and spinal cord ( Figs  1-4) . Primary visual cortex was relatively spared. Subcortical white matter tracts showed marked axonal loss and distorted axonal 20 profiles (Fig. 5) . TDP-43 immunoreactivity was severe in most cases consisting of dense TDP-43 positive rounded and threadlike (Fig. 6 ). In the most severely affected cases, there were dense cortical TDP-43 inclusions and neurites in all neocortical layers, particularly layer II, as well as occasional TDP-43-positive inclusions in the dentate fascia of the hippocampus.
Clinical symptoms
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Family interview and medical record review were available on 13 subjects with stage IV CTE; all were symptomatic. Executive dysfunction and memory loss were the most common symptoms at onset, and all developed severe memory loss with dementia during their course. Most subjects also showed profound loss of attention and concentration, executive dysfunction, language dif-5 ficulties, explosivity, aggressive tendencies, paranoia, depression, gait and visuospatial difficulties. Less common symptoms were impulsivity, dysarthria and parkinsonism; 31% were suicidal at some point in their course. Two of the 13 subjects developed symptoms of MND years after developing cognitive and behav-10 ioural abnormalities.
Professional American football players
Of the 35 former professional American football players (34 National Football League and one Canadian Football League), one showed no disease (Case 27, age 26 years), three had 15 stage I/IV disease, three had stage II/IV, nine had stage III/IV disease, seven had stage IV/IV disease, two had CTE plus Alzheimer's disease, four had CTE plus Lewy body disease, two had CTE plus Alzheimer's disease and Lewy body disease, four had CTE plus FTLD and three had CTE-MND. One National Football
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League player had a primary diagnosis of Pick's disease with only modest evidence of CTE (Case 102), one had a primary diagnosis of Lewy body disease with stage II CTE (Case 95) and another had a primary diagnosis of progressive supranuclear palsy with stage II CTE (Case 101). Thirty-one of the 34 former professional
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American football players had stage III-IV CTE or CTE plus co-morbid disease (89%). Sixteen former National Football League players had pure CTE stage III-IV (47%), 94% were symptomatic; the most common presenting symptoms were short-term memory loss, executive dysfunction and attention and concentration loss.
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Mean age at symptom onset was 54.1 AE 14.1 years (range 34-83 years). Positions played by National Football League players positive for CTE included offensive linemen (26%), running backs (20%), defensive linemen (14%), linebackers (14%), quarterbacks (6%), defensive backs (6%), tight ends (6%) and wide receivers (6%).
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Mean age at death for former National Football League players diagnosed with CTE was 67.1 AE 16.6 years (range 38-98 years).
Professional hockey players
Of the five former professional hockey players, the brain of one young player showed no signs of CTE (age 20 years). were also reported in Goldstein et al. (2012) ].
Cause of death and suicide
Among the 51 subjects with CTE and CTE-MND, there were seven deaths from suicide; six others clearly expressed suicidal ideations at some point during their life (26% suicidal tendencies or com-85 pleted suicide, 14% completed suicide). There were six deaths from drug or alcohol overdose (12%). The most common causes of death were respiratory failure (60% associated with CTE-MND), cardiac disease, suicide, overdose, failure to thrive associated with end-stage dementia and malignancy.
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Discussion CTE is a progressive tauopathy with distinctive clinical and pathological features that occurs after repetitive mild traumatic brain injury. Although historically, CTE has been primarily associated with boxing, CTE may also occur as a consequence of American 95 football, hockey, wrestling, rugby and exposure to blast or concussive injury associated with military service (Corsellis and Brierley, 1959; Corsellis et al., 1973; Hof et al., 1991; McKenzie et al., 1996; Geddes et al., 1999; Omalu et al., 2005 Omalu et al., , 2006 Omalu et al., , 2010 McKee et al., 2009 McKee et al., , 2010 Gavett et al., 2010 Gavett et al., , 2011 Costanza 100 et al., 2011; Daneshvar et al., 2011a, b; Stern et al., 2011; Baugh et al., 2012; Goldstein et al., 2012; Saing et al., 2012) . We analysed the brains of 85 individuals with a history of repetitive mild traumatic brain injury and found evidence of CTE in 80%; all males, ranging in age from 17 to 98 years (mean = 59.5 years), including 64 athletes, 21 military veterans (most of whom were 5 also athletes) and one individual who engaged in self-injurious head-banging behaviour. The development of CTE in one individual in this series and two others in the literature in whom self-injurious head banging was the sole environmental exposure suggests that repetitive mild traumatic brain injury alone is suffi-10 cient to trigger CTE in some people (Hof et al., 1991; Geddes et al., 1999 and by others (Hof et al 1991; Geddes et al., 1999) are distinctive from p-tau pathology of the Alzheimer type reported in some cognitively normal young adults (Braak and Del Tredici, 2011) and in association with other environmental exposures (Anthony et al., 2010) . The tau isoform profile and phosphorylation state in
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CTE is similar to Alzheimer's disease (Schmidt et al., 2001) , and the neuronal tau pathology shows immunoreactivity to both 3R and 4R tau. The astrocytic p-tau pathology in CTE is predominantly 4R tau immunopositive; however, it is topographically distinct from the 4R tau immunoreactive thorn-shaped astrocytes 35 that have been reported in the medial temporal lobe in ageing and Alzheimer's disease (Lace et al. 2012; Ló pez-Gonzá lez et al., 2012) . We divided the topographically predictable pattern of p-tau pathology of CTE into four stages. Stage I was characterized by 40 perivascular p-tau neurofibrillary tangles in focal epicentres at the depths of the sulci in the superior, superior lateral or inferior frontal cortex and was clinically associated with headache and loss of attention and concentration. In stage II CTE, neurofibrillary tangles were found in superficial cortical layers adjacent to the focal epi-45 centres and in the nucleus basalis of Meynert and locus coeruleus. Individuals with stage II CTE experienced depression and mood swings, explosivity, loss of attention and concentration, headache and short-term memory loss. Stage III CTE showed macroscopic evidence of mild cerebral atrophy, septal abnormalities, ventricular 50 dilation, a sharply concave contour of the third ventricle and depigmentation of the locus coeruleus and substantia nigra. There was dense p-tau pathology in medial temporal lobe structures (hippocampus, entorhinal cortex and amygdala) and widespread regions of the frontal, septal, temporal, parietal and insular 55 cortices, diencephalon, brainstem and spinal cord. Most individuals with stage III CTE demonstrated cognitive impairment with memory loss, executive dysfunction, loss of attention and concentration, depression, explosivity and visuospatial abnormalities. Stage IV CTE was associated with further cerebral, medial tem-60 poral lobe, hypothalamic, thalamic and mammillary body atrophy, septal abnormalities, ventricular dilation and pallor of the substantia nigra and locus coeruleus. Microscopically, p-tau pathology involved widespread regions of the neuraxis including white matter, with prominent neuronal loss and gliosis of the cerebral 65 cortex and hippocampal sclerosis. Subjects with stage IV CTE were uniformly demented with profound short-term memory loss, executive dysfunction, attention and concentration loss, explosivity and aggression. Most also showed paranoia, depression, impulsivity and visuospatial abnormalities. Advancing pathological stage 70 was associated with a significant decrease in brain weight and increased severity of cognitive abnormalities supporting the validity of the pathological staging scheme. In addition, pathological stage correlated with duration of exposure to American football, survival after football and age at death in those who played 75 football.
Spread of tau pathology
Under normal conditions in the mature human CNS, tau is primarily associated with microtubules in axons, where it is neither toxic nor associated with neurofibrillary pathology. Brain trauma causes 80 some tau to become dissociated from microtubules in axons via mechanisms that most likely include intracellular calcium influx, glutamate receptor-mediated excitotoxicity and kinase activation mediating hyperphosphorylation of intracellular tau (Genis et al., 2000; Liang et al., 2009; Chen et al., 2010; Tran et al., 2011a, b; 85 Schoch et al., 2012) . Tau dissociated from microtubules may become abnormally phosphorylated, misfolded, aggregated and proteolytically cleaved by calpains and caspases, all of which are associated with neurotoxicity (Amadoro et al., 2006; Khlistunova et al., 2006; Zilka et al., 2006) . Direct and indirect evidence for 90 interneuronal tau transfer in animal models has recently suggested that interneuronal spreading of tau pathology may be due to transfer of toxic tau species between neurons (Clavaguera et al., 2009; Kim et al., 2010; DeCalignon et al., 2012; Liu et al., 2012) . This might be mediated by either a prion-like templated misfolding 95 of tau (Guo et al., 2011; DeCalignon et al., 2012; Liu et al., 2012;  reviewed by Hall and Patuto, 2012) or by calcium dysregulatory effects of oligomeric or toxic N-terminal tau in the receiving neuron (Park and Ferreira, 2005; Frost et al., 2009) . Although spreading of tau pathology is generally thought to occur in asso-100 ciation with neuronal synapses, glial to glial spread, periventricular and diffuse extracellular tau migration patterns. CSF fluid enters the brain parenchyma along the Virchow-Robin spaces surrounding penetrating arteries, and brain interstitial fluid is cleared along paravenous drainage pathways suggesting a possible spread of tau 105 pathology through this route, similar to the clearance of amyloid-ß peptide. Recent studies have demonstrated that amyloid-ß peptide (Iliff et al., 2012) . Clearance through paravenous flow and the CSF might also regulate extracellular levels of p-tau and TDP-43 and explain the frequent perivascular, subpial and periventricular localization of these proteins.
Axonal injury and TDP-43
In addition to p-tau pathology, axonal injury was apparent in all 5 stages of CTE, ranging from multifocal, often perivascular, axonal varicosities in the cortex and subcortical white matter in stages I-II to severe, diffuse axonal loss in the cortex and white matter in CTE stages III-IV. TDP-43 abnormalities were also found in the majority of CTE cases. In CTE stages I-III, sparse TDP-43 neurites were found in various regions of the cortex, medial temporal lobe and brainstem. In stage IV CTE, TDP-43 immunoreactivity was severe, with intraneuronal and intraglial inclusions, rounded and threadlike neurites in the cortex, white matter, diencephalon, basal ganglia and brainstem. Although it is well-established that p-tau 15 pathology correlates with the severity of cognitive impairment in other tauopathies, such as Alzheimer's disease (Wilcock and Esiri, 1982; McKee et al., 1991; Arriagada et al., 1992) , the contribution of TDP-43 proteinopathy to symptoms of CTE cannot be overlooked, especially in late stage disease. As with frontotem-20 poral dementia, CTE usually begins with behaviour and personality changes at mid-life (mean age of onset 44.3 years, range 17-83 AE 12.1 years). But, unlike Alzheimer's disease or frontotemporal dementia, the clinical course of CTE is slow, progressing at a rate of 11-14 years between pathological stages. In addition, it 25 is likely that axonal dysfunction and loss contribute to the production of clinical symptoms, especially in the early stages of CTE when tau pathology is focal and unlikely to account for the headache, attention and concentration loss, and memory difficulties experienced by subjects with stage I or II disease. Although the 30 data suggest that CTE pathology is progressive, it remains to be determined whether some individuals are relatively resilient with static or even reversible pathology. Eleven per cent of individuals with CTE were asymptomatic, with a mean age at death of 59 years (range 26-87 years) and most with stage II disease, suggest-
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ing that CTE may not progress or may not progress at the same rate in all patients.
Chronic traumatic encephalopathy plus comorbid neurodegenerative disease
Of the 68 cases with CTE, 37% had co-morbid neurodegenerative 40 disease, including MND, Parkinson's disease or Lewy body disease, Alzheimer's disease and FTLD. Repetitive traumatic brain injury and axonal injury might trigger molecular pathways that result in the overproduction and aggregation of other proteins prone to pathological accumulation in neurodegenerative disease including 45 TDP-43, -synuclein and amyloid-ß, thereby increasing the likelihood of MND, FTLD Lewy body disease or Alzheimer's disease. Multiple epidemiological studies have shown that trauma is a risk factor for dementia, especially Alzheimer's disease, as well as for amyotrophic lateral sclerosis and Parkinson's disease (Plassman 50 et al., 2000; Goldman et al., 2006; Schmidt et al., 2010; Pupillo et al., 2012) . In addition, CTE and the accumulation of misfolded tau aggregates may promote the aggregation of pathological proteins through cross-seeding (Johan et al., 1998; Morales et al., 2009 ). Cross-seeding might explain the accumulation of TDP-43 55 in the large majority of CTE cases, its partial immunohistochemical co-location with tau and the particularly severe deposition of TDP-43 found in advanced CTE.
Chronic traumatic encephalopathy with motor neuron disease
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Most subjects with CTE-MND (63%) presented with symptoms of MND, developing cognitive and behavioural symptoms several years after the onset of motor weakness, atrophy and fasciculations. The minority presented with apathy, depression, memory loss, cognitive decline, paranoia, impulsivity or executive dysfunc-65 tion 1-8 years before the development of motor neuron symptoms. There was a tendency for subjects with CTE-MND to die from respiratory insufficiency at an earlier age (53.0 AE 14.3 years) than those without MND (55.8 AE 23.0 years), although the difference was not significant. Individuals with MND and CTE, inde- 
Clinicopathological correlation
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Neuroanatomical areas that are preferentially affected in CTE include superior, dorsolateral and lateral frontal cortices. Pathology in these regions may underlie the clinical features of disinhibition, lack of insight and poor executive function found in subjects even at early stages of CTE. Pathological involvement of the inferior 80 temporal lobe and amygdala might contribute to the frontal symptoms and to the irritability, impulsivity, explosivity and outbursts of aggression so commonly experienced as early manifestations of CTE. Pathology of the nucleus basalis of Meynert and septal nuclei might contribute to the cognitive symptoms.
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Moreover, pathology in the subcallosal and inferior orbital frontal cortex and brainstem, especially the locus coeruleus and median raphe, might be related to the common symptoms of depression and mood lability. Mammillary body, anterior thalamic and hippocampal pathology most likely play a major role in producing 90 memory loss, cognitive impairment and eventual dementia.
Even though the brain donors were not screened for cognitive impairments, an autopsy-based case series is limited by significant ascertainment bias, as families of individuals showing behavioural or cognitive symptoms are much more likely to initiate and par-95 ticipate in a brain donation programme than families of normally functioning individuals. Consequently, no generalizations regarding the incidence and prevalence of CTE in living athletes and veterans can be made. Furthermore, in several of the cases, the clinical symptoms were confounded by drug and alcohol abuse; 100 therefore, the degree to which the extensive p-tau, TDP-43 and axonal pathology and neurodegeneration is responsible for the subject's clinical presentation is unclear.
Inclusion of more rigorous control subjects, such as individuals who experienced repetitive mild traumatic brain injury and did not 105 develop behavioural or cognitive abnormalities, will be extremely useful in future studies designed to delineate critical aspects of the traumatic exposure and susceptibility to trauma-induced neurodegeneration.
Future prospective longitudinal studies are planned to address these limitations. For instance, by studying a large number of retired National Football League athletes prospectively and conducting neuropathological analyses at death, a control group 5 matched on age, education, athletic history, medical comorbidities and cause of death can be used to examine differences between individuals with and without clinical and neuropathological evidence of Similarly, current studies focused on a large cohort of Iraq and Afghanistan veterans with histories of blast and concus-sive traumatic brain injuries and post-traumatic stress disorder will shed light on the overlap between traumatic brain injury, CTE and post-traumatic stress disorder, as well as the role of combat-associated injury in producing CTE (Goldstein et al, 2012) . Clinical criteria for the diagnosis of CTE need to be estab-15 lished and tested. Although ApoE does not appear to be a risk factor for the development of CTE or the severity of CTE pathology in this autopsy series, large prospective population-based studies need to be implemented to address this definitively (Gandy and DeKosky, 2012) . The current results establish that a 20 distinctive pattern of neuropathological changes, previously reported primarily in boxers, can also be found in other athletes and military veterans and provide a clear impetus for future studies.
CTE is a unique neurodegenerative condition that is associated 25 with repetitive mild traumatic brain injury. Although there are many issues that require more thorough investigation, such as how much head trauma is causative, what type, and how frequent, the age when players are most susceptible and whether some individuals are genetically more prone than others, this study 30 clearly shows that for some athletes and war fighters, there may be severe and devastating long-term consequences of repetitive brain trauma that has traditionally been considered only mild.
